Skip to content

CFS_CARE care study for patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Rehabilitation of patients with chronic fatigue syndrome.

CFS_CARE care study for patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Rehabilitation of patients with chronic fatigue syndrome. - ME/CFS-REHA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00028115
Enrollment
120
Registered
2022-02-18
Start date
2022-04-21
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G93.3

Interventions

Group 1: In the intervention arm, patients receive extended diagnostics and therapy in the form of five-week inpatient rehabilitation. The patients in the intervention arm are expected to be admitted

Sponsors

Klinik Bavaria Kreischa
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Participants are patients diagnosed with ME/CFS. The onset of the disease must not be more than five years ago.

Exclusion criteria

Exclusion criteria: Other conditions associated with chronic fatigue, e.g. B. post-cancer fatigue; insufficient written and spoken German language skills and persons not able to consent.

Design outcomes

Primary

MeasureTime frame
health-related quality of life (SF-36) at 12 months

Secondary

MeasureTime frame
ability to work (able to work yes/no, sick days); health status (Bell scale, SF-36); symptoms (Chalder Fatigue Scale, CCC criteria, COMPASS, IPAQ, EQ5D, PHQ9, ESS); physical or apparatus functional parameters (hand strength, number of steps, activity, orthostasis, vascular function)

Countries

Germany

Contacts

Public ContactKatrin Mehnert

Wiss. Institut der Klinik Bavaria Kreischa

Katrin.Mehnert@klinik-bavaria.de0049 (0) 35206-6-1233

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026